Healthcare Triangle, Inc. (HCTI) Stock Analysis

Healthcare Triangle, Inc. (HCTI) Stock Analysis

Overall Grade: F (Concerning)

View interactive company profile →

Healthcare Triangle, Inc. faces challenges in financial performance that warrant careful analysis.

Key Metrics:

Metric Value Context
ROIC -130.7% Below expectations
FCF Margin -81.1% Cash flow pressure

Investment Thesis: Financial metrics indicate concerning business quality with areas requiring attention.


What is Healthcare Triangle, Inc.'s Profitability and ROIC?

Healthcare Triangle, Inc.'s return on invested capital of -130.7% is below the typical cost of capital. Gross margin of 8276.9% with operating margin at -45.2% reflects the company's strong market position.

Key Metrics

Metric Value Rating Interpretation
Return on Invested Capital (ROIC) -130.7% Red flag Below cost of capital
Return on Equity (ROE) -141.5% Red flag Moderate equity returns
Gross Margin 8276.9% Excellent Strong pricing power
Operating Margin -45.2% Warning Moderate operational efficiency

How Strong is Healthcare Triangle, Inc.'s Cash Flow Quality?

Healthcare Triangle, Inc. generated $-10.5M in free cash flow over the trailing twelve months, representing a -81.1% margin. Cash earnings quality is strong, with operating cash flow exceeding net income by 1.7x.

Key Metrics

Metric Value Rating Interpretation
Free Cash Flow Margin -81.1% Red flag Thin cash margins
Free Cash Flow (TTM) $-10.5M Red flag Cash burn
OCF/Net Income 1.7x Excellent High earnings quality
FCF Consistency (8Q) N/A Warning Variable cash flow

What is Healthcare Triangle, Inc.'s Financial Health?

Healthcare Triangle, Inc. maintains a net cash position of $99000, providing significant financial flexibility.

Key Metrics

Metric Value Rating Interpretation
Net Cash Position $99000 Excellent Net cash positive

Is Healthcare Triangle, Inc. Stock Overvalued or Undervalued?

Healthcare Triangle, Inc. trades at a P/E of 0.0x, representing a premium to the sector median of N/A. Free cash flow yield of -42.4% reflects market expectations for growth.

Key Metrics

Metric Value Rating Interpretation
P/E Ratio 0.0x Adequate Reasonable valuation
EV/Sales 1.8x Excellent Attractive revenue multiple
FCF Yield -42.4% Warning Lower cash yield

Sector Rankings

Metric Value Percentile vs Median
Return on Invested Capital (ROIC) -130.7% Top 5% -20.2x below
Free Cash Flow Margin -81.1% Bottom 10% -8.1x below
Gross Margin 8276.9% Top 5% 156.4x above
Operating Margin -45.2% Top 5% -7.2x below
Return on Equity (ROE) -141.5% Top 5% -22.7x below
P/E Ratio 0.0x N/A -

Rating Thresholds

Return on Invested Capital (ROIC)

Measures how efficiently a company uses its debt and equity capital to generate profits. ROIC above 15% typically indicates a competitive moat.

Rating Range Interpretation
Excellent > 20% Exceptional capital efficiency, strong competitive moat
Good 12% - 20% Above-average returns, sustainable competitive position
Adequate 8% - 12% Around cost of capital, moderate competitive position
Warning 4% - 8% Below cost of capital, value may be eroding
Red flag < 4% Significant capital destruction, fundamental issues

Current: -130.7% (Red flag - Top 5% of sector (median: 6.5%))

Free Cash Flow Margin

The percentage of revenue converted to free cash flow. Higher margins indicate stronger cash generation and business quality.

Rating Range Interpretation
Excellent > 20% Strong cash generation, high-quality business
Good 10% - 20% Healthy cash conversion
Adequate 5% - 10% Moderate cash generation
Warning 0% - 5% Thin cash margins, capital intensive
Red flag < 0% Cash burn, potential liquidity concerns

Current: -81.1% (Red flag)

Gross Margin

Revenue minus cost of goods sold as a percentage. Higher gross margins indicate pricing power and competitive advantage.

Rating Range Interpretation
Excellent > 50% Strong pricing power and competitive moat
Good 30% - 50% Healthy margins, differentiated product
Adequate 20% - 30% Moderate margins, competitive industry
Warning 10% - 20% Thin margins, commodity-like business
Red flag < 10% Very thin margins, structural challenges

Current: 82.8x (Excellent - Top 5% of sector (median: 52.9%))

P/E Ratio (Price-to-Earnings)

Stock price divided by earnings per share. Lower P/E may indicate undervaluation, while higher P/E suggests growth expectations.

Rating Range Interpretation
Excellent < 15x Attractively valued, potential opportunity
Good 15x - 25x Fair value for quality company
Adequate 25x - 35x Growth premium, justify with earnings growth
Warning 35x - 50x High expectations priced in
Red flag > 50x or negative Speculative valuation or losses

Current: 1.2% (Adequate)

Free Cash Flow Yield

Free cash flow per share divided by stock price. Higher FCF yield indicates better cash return relative to valuation.

Rating Range Interpretation
Excellent > 8% High cash return, potential value opportunity
Good 5% - 8% Solid cash yield
Adequate 3% - 5% Moderate cash return
Warning 1% - 3% Low cash yield, growth expectations
Red flag < 1% Minimal cash return to shareholders

Current: -42.4% (Red flag)


Frequently Asked Questions

Q: What is Healthcare Triangle, Inc.'s Return on Invested Capital (ROIC)?

Healthcare Triangle, Inc. (HCTI) has a trailing twelve-month Return on Invested Capital (ROIC) of -130.7%. This compares below the sector median of 6.5%. An ROIC below 8% suggests the company may be destroying shareholder value.

Q: What is Healthcare Triangle, Inc.'s Free Cash Flow Margin?

Healthcare Triangle, Inc. (HCTI) has a free cash flow margin of -81.1%, generating $-10.5 million in free cash flow over the trailing twelve months. Negative free cash flow means the company is consuming cash, which may require financing.

Q: Is Healthcare Triangle, Inc. stock overvalued or undervalued?

Healthcare Triangle, Inc. (HCTI) trades at a P/E ratio of 0.0x, which is above the sector median of N/A. The EV/Sales multiple is 1.8x.

Q: What is Healthcare Triangle, Inc.'s revenue and earnings growth?

Healthcare Triangle, Inc. (HCTI) declined revenue by 21.9% year-over-year. Net income grew by 34.0% year-over-year. Revenue decline may indicate market challenges or industry headwinds.

Q: How does Healthcare Triangle, Inc. compare to competitors in Technology?

Compared to other companies in Technology, Healthcare Triangle, Inc. (HCTI) shows: ROIC of -130.7% is below the sector median of 6.5% (Top -770%). FCF margin of -81.1% trails the sector median of 10.0%. Gross margin at 8276.9% is 8224 percentage points higher than sector peers. These rankings are based on MetricDuck's analysis of all Technology companies with available SEC filings.

Q: What warning signs should I watch for with Healthcare Triangle, Inc.?

Investors in Healthcare Triangle, Inc. (HCTI) should monitor these potential warning signs: 1) FCF margin is thin at -81.1%, leaving limited buffer for economic downturns. Regular monitoring of SEC filings and quarterly trends is recommended.


Data Source: Data sourced from 10-Q filed 2025-11-13. TTM metrics as of Q3 2025.

Methodology: Financial metrics calculated from SEC 10-K and 10-Q filings using standardized formulas. Sector comparisons use peer group based on SIC code.

This analysis is for informational purposes only and does not constitute investment advice.